Dr. Rajadas is currently working on the molecular mechanism of protein-initiated neurodegenerative disorders involved in Alzheimer’s and Lyme disease development using biophysical approaches such as AFM, fluorescence, and NMR. He is head of the BioADD Laboratory and Assistant Director of Cardiovascular Pharmacology at Stanford School of Medicine. His recent research, funded by Bay Area Lyme Foundation, identified 20 FDA-approved compounds that were more effective in inhibiting persistent Lyme bacteria than standard antibiotic treatment. Dr. Rajadas received his M.S. in Chemistry from University of Madras and Ph.D. in Biophysical Chemistry from Indian Institute of Technology.
Director of the Biomaterials and Advanced Drug Delivery Lab (BioADD) and Assistant Director of Cardiovascular Pharmacology at Stanford School of Medicine